South San Francisco, CA September 2, 2023 Press Release ALINA data demonstrate Alecensa reduces disease recurrence in the early setting for people with ALK-positive non-small cell lung cancer (NSCLC), building on its long-established benefit in the advanced setting About half…
South San Francisco, CA August 23, 2023 Press Release South San Francisco, CA — August 22, 2023 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it has been made aware of an…
South San Francisco, CA August 12, 2023 REEDLEY, CA – A LESSON TO BE LEARNED Many residents in South San Francisco have questioned the safety of the biolabs in our City as the numbers of life science developments continue to…
South San Francisco, CA August 12, 2023 – EPA Press Release 8/8/23 SAN FRANCISCO – Today, the U.S. Environmental Protection Agency announced a settlement with Genentech, a biopharmaceutical manufacturer based in South San Francisco, for claims of hazardous waste violations…
South San Francisco, CA July 17, 2023 Press Release Investing in the power of community to advance health equity The Community Health Justice Fund is a three-year, $6 million commitment to community-based organizations improving the health of their communities…
South San Francisco, CA July 2, 2023 Press Release Four-Year Follow-Up Data for Genentech’s Evrysdi Show Continued Increase in Number of Children With a Severe Form of Spinal Muscular Atrophy (SMA) Able to Sit, Stand and Walk Data from ongoing…
South San Francisco, CA April 23, 2023 Press Release Genentech Announces Industry-Leading Brain Health Research Collaborations and Latest Data Across Neuroscience Medicines at AAN 2023 Annual Meeting Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis,…
South San Francisco, CA April 18, 2023 Press Release Genentech’s Tecentriq Plus Avastin Reduced the Risk of Cancer Returning in People With Certain Types of Adjuvant Liver Cancer in a Phase III Study In the first-ever positive Phase III…
South San Francisco, CA March 20, 2023 Press Release New Four-Year Data for Genentech’s Evrysdi Reinforce Long-Term Efficacy and Safety Profile in Some of the Most Severely Affected People With Types 2 and 3 Spinal Muscular Atrophy (SMA) Data…
South San Francisco, CA September 26, 2022 Press Release Futurelab+ is a $10 Million Expansion of Genentech’s Original South San Francisco Futurelab Program South San Francisco, CA – September 26, 2022 – Genentech, a member of the Roche…